Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-01-30
2007-01-30
Nickol, Gary B. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S325000, C435S455000, C530S350000, C536S023500
Reexamination Certificate
active
09869565
ABSTRACT:
The invention provides a novel PTH receptor polypeptide, rΔNt, characterized by a deletion of the extracellular amino-terminus, ligand binding domain of the receptor. Additionally disclosed are nucleic acid molecules encoding the receptor. The receptor has a minimal domain for ligand binding and is useful in screening assays designed for the identification of agonists and antagonists of PTH receptor activity.
REFERENCES:
patent: 4086196 (1978-04-01), Tregear
patent: 5217896 (1993-06-01), Kramer et al.
patent: 5494806 (1996-02-01), Segre et al.
patent: 6417333 (2002-07-01), Bringhurst et al.
patent: 6495662 (2002-12-01), Gardella et al.
patent: 6537965 (2003-03-01), Bringhurst et al.
patent: 6541220 (2003-04-01), Jüppner et al.
patent: 6803213 (2004-10-01), Bringhurst et al.
patent: 2003/0144209 (2003-07-01), Bringhurst et al.
patent: 2003/0162256 (2003-08-01), Juppner et al.
patent: 2003/0166838 (2003-09-01), Gardella et al.
patent: 2005/0026839 (2005-02-01), Gardella
patent: 2126132 (1995-12-01), None
patent: 2126299 (1995-12-01), None
patent: 0 464 533 (1992-01-01), None
patent: 0 477 885 (1992-04-01), None
patent: 0 561 412 (1993-09-01), None
patent: 0 748 817 (1996-12-01), None
patent: 2 269 176 (1994-02-01), None
patent: WO 87/01130 (1987-02-01), None
patent: WO 91/05050 (1991-04-01), None
patent: WO 92/01810 (1992-02-01), None
patent: WO 92/17602 (1992-10-01), None
patent: WO 95/11988 (1995-05-01), None
patent: WO 97/02834 (1997-01-01), None
patent: WO 98/05683 (1998-02-01), None
patent: WO 99/18945 (1999-04-01), None
patent: WO 00/31137 (2000-06-01), None
patent: WO 00/32775 (2000-06-01), None
patent: WO 00/39278 (2000-07-01), None
patent: WO 01/23427 (2001-04-01), None
patent: WO 01/23521 (2001-04-01), None
patent: WO 00/23594 (2001-08-01), None
patent: WO 00/31266 (2001-09-01), None
patent: WO 00/40698 (2001-10-01), None
patent: WO 03/009804 (2003-02-01), None
patent: WO 2004/067021 (2004-08-01), None
patent: WO 2004/093902 (2004-11-01), None
patent: WO 2005/009358 (2005-02-01), None
Chorev et al. (1991) Biochemistry 30(24): 5968-5974.
Goud et al. (1991) J Bone Miner Res 6(8): 781-789.
Horiuchi et al. (1987) Am J Physiol 253: E187-192.
Lee et al. (1995) Mol Endocrinol 9(10): 1269-1278.
Wells (Sep. 18, 1990) Biochemistry 29(37): 8509-8517.
Ngo et al. (Mar. 2, 1995) “The Protein Folding Problem and Tertiary Structure Prediction, Chapter 14: Computational Complexity Protein Structure Prediction, and the Levinthal Paradox” pp. 492-495.
Bork (2000)Genome Research10:398.
Skolnick and Fetrow (2000)Trends in Biotech. 18(1): 34.
Doerks et al. (Jun. 1998)Trend in Genetics14(6): 248.
Smith and Zhang (Nov. 1997)Nature Biotechnology15:1222.
Brenner (Apr. 1999)Trends in Genetics15(4): 132.
Bork and Bairoch (Oct. 1996)Trends in Genetics12(10): 425.
Sunyaev et al. 2004. Proteins: Structure, Function and Bioinformatics. 54: 569-582.
Vogt et al. 1995. J Mol Biol. 249: 816-831.
Abou-Samra, A.B., et al., “Phorbol 12-Myristate 13-Acetate and Vasopressin Potentiate the Effect of Corticotropin-releasing Factor on Cyclic AMP Production in Rat Anterior Pituitary Cells,”J. Biol. Chem. 262:1129-1136, The American Society for Biochemistry and Molecular Biology, Inc. (1987).
Abou-Samra, A.B., et al., “Cyclic Andenosine 3′, 5′ -Monophosphate (cAMP)—Dependent and cAMP-Independent Regulation of Parathyroid Hormoe Receptors on UMR 106-01 Osteoblastic Osteosarcoma Cells,”Endocrinology 129:2547-2554, The Endocrine Society (1991).
Abou-Samra, A.B., et al., “Non-Homologous Sequences of Parathyroid and the Parathyroid Hormone Relateed Peptied Bind to a Common Recceptor on ROS 17/2.8 Cells,”Endocrinology 125:2215-2217, The Endocrine Society (1989).
Azarani, A., et al., “Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the NA+/H+Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways, ”J. Biol. Chem. 271:14931-14936, The American Society for Biochemistry and Molecular Biology, Inc. (1996).
Barbier, J.-R., et al., “Bioactivities and Secondary Structures of Constrained Analogues of Human Parathyroid Hormone: Cyclic Lactams of the Receptor Binding Region,”J. Med. Chem. 40:1373-1380, Americna Chemical Society (Apr. 1997).
Bennett, D., et al., “Kinetic Characterization of the Interaction of Biotinylated Human Interleukin 5 with an Fc Chimera of its Receptor α Subunit and Development of a ELISA Screening Assay using Real-Time Interaction Biosensor Analysis, ”J. Molec. Recognition 8:52-58, John Wiley & Sons, Ltd. (1995).
Bergwitz, C., et al., “Full Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin,”J. Biol. Chem. 271:26469-26472, The American Society for Biochemistry and Molecular Biology, Inc. (1996).
Bergwitz, C., et al., “Residues in the Membrane-spanning and Extracellular Loop Regions of the Parathyroid Hormone (PTH)-2 Receptor Determine Signaling Selecivity for PTH and PTH-related Peptide,”J. Biol. Chem. 272:28861-28868, The American Society for Biochemistry and Molecular Biology, Inc. (Nov. 1997).
Bisello, A., et al., “Parathyroid Hormone-Receptor Interactions Identified Directly by Photocross-linking and Molecular Modeling Studies,”J. Biol. Chem. 273:22498-22505, The American Society for Biochemistry and Molecular Biology, Inc. (Aug. 1998).
Bowie, J.U., et al., “Deciphering the Message in Protein Seuences: Tolerance to Amino Acid Substitutions,”Science 247:1306-1310, American Association for the Advancement of Science (1990).
Caulfield, M.P., et al., “The Bovine Renal Parathyroid Hormone (PTH) Receptor Has Equal Affinity for Two Different Amino Acid Sequences: The Receptor Binding Domains of the PTH and PTH-Related Protein Are Located within the 14-34 Region”Endocrinology 127:83-87, The Endocrine Society (1990).
Chorev, M., et al., “Modifications of Position 12 in Parathyroid Hormone and Parathyroid Hormone Related Protein: Thyroid the Design of Highly Potent Antagonists,”Biochem. 29:1580-1586, American Chemical Society (1990).
Cleland, J.L., et al., “The Development of Stable Protein Formulations: A Close Look at Protein Aggregation, Deamidation, and Oxidation,”Crit. Rev. Ther. Drug Carrier Systems 10:307-377, CRC Press, Inc. (1993).
Cohen, F.E., et al., “Analogues of Parathyroid Hormone Modified at Positions 3 and 6. Effects on Receptor Binding and Activation of Adenylyl Cyclase in Kidney and Bone,”J. Biol. Chem. 266:1997-2004, The American Society for Biochemistry and Molecular Biology, Inc. (1991).
Cunningham, B.C., and Wells, J.A., “High-Resolution Epitope Mapping of hGH-Receptor Interactions by Alanine-Scanning Mutagenesis,”Science 244:1081-1085, American Association for the Advancement of Science (1989).
Dautzenberg, F., et al., “Mapping of the ligand-selective domain of theXenopus laeviscorticotropin-releasing factor receptor 1: Implications for the ligand-binding site,”Proc. Natl. Acad. Sci. USA 95:4941-4946, National Academy of Sciences (Apr. 1998).
de Vos, A.M., et al., “Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex,”Science 255:306-312, American Association for the Advancement of Science (1992).
DeAlmeida, V., and Mayo, K., “Identification of Binding Domains of the Growth Hormone-Releasing Hormone Receptor by Analysis of Mutant and Chimeric Receptor Proteins,”Mol. Endocrinol. 12:750-765, The Endocrine Society (May 1998).
Dempster, D.W., et al., “Anabolic Actions of Parathyroid Hormone on Bone,”Endocr. Rev. 14:690-709, The Endocrine Society (1993).
Donahue, H.J., et al., “Differential Effects of Parathyroid Hormone and Its Analogues on Cytosolic Calcium Ion and cAMP Levels in Cultured Rat Osteoblast-like Cells,”J. Biol. Chem. 263:13522-13527, The American Society for
Gardella Thomas J.
Kronenberg Henry M.
Potts John T.
Howard Zachary C.
Nickol Gary B.
Sterne Kessler Goldstein & Fox P.L.L.C.
The General Hospital Corporation
LandOfFree
Screening assay utilizing the PTH receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening assay utilizing the PTH receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening assay utilizing the PTH receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3721527